Pressreleases

Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C

SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, is introducing optimised SCHOTT TOPPAC® freeze polymer syringes, designed to protect medications at temperatures as low as -180°C.

Redefining Safety, Efficiency, and Sustainability: SCHOTT Pharma Launches Next-Generation Polymer Syringe System

SCHOTT Pharma, a pioneer in drug containment and delivery solutions, launches the next generation of SCHOTT TOPPAC® infuse polymer syringes, a system designed to improve safety, efficiency, and sustainability in healthcare.

Showing Expanded Advanced Modelling Methods at HPLC 2026 Indianapolis

The MOLNÁR-INSTITUTE for Applied Chromatography will again be a prominent presence as an exhibitor at the latest edition of the International Symposium on High Performance Liquid Phase Separations (HPLC 2026), this time in the US city of Indianapolis.

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients

As biologic therapies continue to rise for treating cancer, autoimmune, and neurological diseases, drug containment and delivery solutions are evolving to meet these new therapeutic demands.

SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge

As the biologics market continues to expand, fuelled by breakthroughs such as cell and gene therapies, drug developers face increasing demand for safe, patient-friendly delivery and administration solutions.

Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe

The global large-volume injectors market is expected to witness substantial growth over the next decade, driven by factors such as the rising prevalence of chronic diseases, a shift towards homecare, and technological advancements in injector devices.

Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma

Christian Mias, born in Iserlohn in 1974, will succeed Andreas Reisse starting May 1st. As an industrial engineer with a doctoral degree, he looks back on more than 20 years of management experience, including over 18 years within the SCHOTT group.

LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announced the successful closing of its acquisition of Renaissance

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer, a global systems and solutions provider specialising in pharmaceutical packaging and drug delivery devices, will present its extensive portfolio of high-value solutions for innovative therapies at this year’s CPHI Trade Fair in Frankfurt, Germany, from October 28th to 30th, 2025, in Hall 8 at Booth 8.OG8.